These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1287 related items for PubMed ID: 30806619

  • 1. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
    Morrison AP, Pyle M, Gumley A, Schwannauer M, Turkington D, MacLennan G, Norrie J, Hudson J, Bowe S, French P, Hutton P, Byrne R, Syrett S, Dudley R, McLeod HJ, Griffiths H, Barnes TR, Davies L, Shields G, Buck D, Tully S, Kingdon D.
    Health Technol Assess; 2019 Feb; 23(7):1-144. PubMed ID: 30806619
    [Abstract] [Full Text] [Related]

  • 2. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H, Landau S, Little P, Bishop FL, O'Reilly G, Sibelli A, Holland R, Hughes S, Windgassen S, McCrone P, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [Abstract] [Full Text] [Related]

  • 3. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
    Serfaty M, King M, Nazareth I, Moorey S, Aspden T, Tookman A, Mannix K, Gola A, Davis S, Wood J, Jones L.
    Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
    [Abstract] [Full Text] [Related]

  • 4. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S, Almeida C, Ambler N, Blair PS, Choy E, Dures E, Hammond A, Hollingworth W, Kadir B, Kirwan J, Plummer Z, Rooke C, Thorn J, Turner N, Pollock J.
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [Abstract] [Full Text] [Related]

  • 5. Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial.
    Morrison AP, Pyle M, Gumley A, Schwannauer M, Turkington D, MacLennan G, Norrie J, Hudson J, Bowe SE, French P, Byrne R, Syrett S, Dudley R, McLeod HJ, Griffiths H, Barnes TRE, Davies L, Kingdon D, FOCUS trial group.
    Lancet Psychiatry; 2018 Aug; 5(8):633-643. PubMed ID: 30001930
    [Abstract] [Full Text] [Related]

  • 6. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L, Kudlicka A, Oyebode JR, Jones RW, Bayer A, Leroi I, Kopelman M, James IA, Culverwell A, Pool J, Brand A, Henderson C, Hoare Z, Knapp M, Morgan-Trimmer S, Burns A, Corbett A, Whitaker R, Woods B.
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [Abstract] [Full Text] [Related]

  • 7. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
    Richards DA, Rhodes S, Ekers D, McMillan D, Taylor RS, Byford S, Barrett B, Finning K, Ganguli P, Warren F, Farrand P, Gilbody S, Kuyken W, O'Mahen H, Watkins E, Wright K, Reed N, Fletcher E, Hollon SD, Moore L, Backhouse A, Farrow C, Garry J, Kemp D, Plummer F, Warner F, Woodhouse R.
    Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
    [Abstract] [Full Text] [Related]

  • 8. Cognitive-behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT.
    Goldstein LH, Robinson EJ, Pilecka I, Perdue I, Mosweu I, Read J, Jordan H, Wilkinson M, Rawlings G, Feehan SJ, Callaghan H, Day E, Purnell J, Baldellou Lopez M, Brockington A, Burness C, Poole NA, Eastwood C, Moore M, Mellers JD, Stone J, Carson A, Medford N, Reuber M, McCrone P, Murray J, Richardson MP, Landau S, Chalder T.
    Health Technol Assess; 2021 Jun; 25(43):1-144. PubMed ID: 34196269
    [Abstract] [Full Text] [Related]

  • 9. A group memory rehabilitation programme for people with traumatic brain injuries: the ReMemBrIn RCT.
    das Nair R, Bradshaw LE, Carpenter H, Clarke S, Day F, Drummond A, Fitzsimmons D, Harris S, Montgomery AA, Newby G, Sackley C, Lincoln NB.
    Health Technol Assess; 2019 Apr; 23(16):1-194. PubMed ID: 31032782
    [Abstract] [Full Text] [Related]

  • 10. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.
    Thomas SA, Drummond AE, Lincoln NB, Palmer RL, das Nair R, Latimer NR, Hackney GL, Mandefield L, Walters SJ, Hatton RD, Cooper CL, Chater TF, England TJ, Callaghan P, Coates E, Sutherland KE, Eshtan SJ, Topcu G.
    Health Technol Assess; 2019 Sep; 23(47):1-176. PubMed ID: 31524133
    [Abstract] [Full Text] [Related]

  • 11. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
    Barnes TR, Leeson VC, Paton C, Marston L, Davies L, Whittaker W, Osborn D, Kumar R, Keown P, Zafar R, Iqbal K, Singh V, Fridrich P, Fitzgerald Z, Bagalkote H, Haddad PM, Husni M, Amos T.
    Health Technol Assess; 2017 Sep; 21(49):1-56. PubMed ID: 28869006
    [Abstract] [Full Text] [Related]

  • 12. Guided self-help for depression in autistic adults: the ADEPT feasibility RCT.
    Russell A, Gaunt D, Cooper K, Horwood J, Barton S, Ensum I, Ingham B, Parr J, Metcalfe C, Rai D, Kessler D, Wiles N.
    Health Technol Assess; 2019 Dec; 23(68):1-94. PubMed ID: 31856942
    [Abstract] [Full Text] [Related]

  • 13. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP, Pyle M, Maughan D, Johns L, Freeman D, Broome MR, Husain N, Fowler D, Hudson J, MacLennan G, Norrie J, Shiers D, Hollis C, James A, MAPS group.
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [Abstract] [Full Text] [Related]

  • 14. Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT.
    Morrison AP, Pyle M, Byrne R, Broome M, Freeman D, Johns L, James A, Husain N, Whale R, MacLennan G, Norrie J, Hudson J, Peters S, Davies L, Bowe S, Smith J, Shiers D, Joyce E, Jones W, Hollis C, Maughan D.
    Health Technol Assess; 2021 Jan; 25(4):1-124. PubMed ID: 33496261
    [Abstract] [Full Text] [Related]

  • 15. Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT.
    Kyle SD, Bower P, Yu LM, Siriwardena AN, Yang Y, Petrou S, Ogburn E, Begum N, Maurer L, Robinson B, Gardner C, Armstrong S, Pattinson J, Espie CA, Aveyard P.
    Health Technol Assess; 2024 Aug; 28(36):1-107. PubMed ID: 39185919
    [Abstract] [Full Text] [Related]

  • 16. Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT.
    Howard R, Cort E, Bradley R, Harper E, Kelly L, Bentham P, Ritchie C, Reeves S, Fawzi W, Livingston G, Sommerlad A, Oomman S, Nazir E, Nilforooshan R, Barber R, Fox C, Macharouthu A, Ramachandra P, Pattan V, Sykes J, Curran V, Katona C, Dening T, Knapp M, Romeo R, Gray R.
    Health Technol Assess; 2018 Nov; 22(67):1-62. PubMed ID: 30507375
    [Abstract] [Full Text] [Related]

  • 17. CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
    Bosanquet K, Adamson J, Atherton K, Bailey D, Baxter C, Beresford-Dent J, Birtwistle J, Chew-Graham C, Clare E, Delgadillo J, Ekers D, Foster D, Gabe R, Gascoyne S, Haley L, Hamilton J, Hargate R, Hewitt C, Holmes J, Keding A, Lewis H, McMillan D, Meer S, Mitchell N, Nutbrown S, Overend K, Parrott S, Pervin J, Richards DA, Spilsbury K, Torgerson D, Traviss-Turner G, Trépel D, Woodhouse R, Gilbody S.
    Health Technol Assess; 2017 Nov; 21(67):1-252. PubMed ID: 29171379
    [Abstract] [Full Text] [Related]

  • 18. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).
    Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, Arundel C, Gilbody S, Gega L, Hardy G, Reynolds S, Barkham M, Mottram P, Lidbetter N, Pedley R, Molle J, Peckham E, Knopp-Hoffer J, Price O, Connell J, Heslin M, Foley C, Plummer F, Roberts C.
    Health Technol Assess; 2017 Jun; 21(37):1-132. PubMed ID: 28681717
    [Abstract] [Full Text] [Related]

  • 19. Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.
    Lincoln NB, Bradshaw LE, Constantinescu CS, Day F, Drummond AE, Fitzsimmons D, Harris S, Montgomery AA, das Nair R.
    Health Technol Assess; 2020 Jan; 24(4):1-182. PubMed ID: 31934845
    [Abstract] [Full Text] [Related]

  • 20. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP, Law H, Carter L, Sellers R, Emsley R, Pyle M, French P, Shiers D, Yung AR, Murphy EK, Holden N, Steele A, Bowe SE, Palmier-Claus J, Brooks V, Byrne R, Davies L, Haddad PM.
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.